Compare FELE & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FELE | ADMA |
|---|---|---|
| Founded | 1944 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | FELE | ADMA |
|---|---|---|
| Price | $96.04 | $19.78 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $107.00 | $28.50 |
| AVG Volume (30 Days) | 233.3K | ★ 2.9M |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | N/A | ★ 205.35 |
| EPS | ★ 3.07 | 0.86 |
| Revenue | ★ $2,110,140,000.00 | $488,559,000.00 |
| Revenue This Year | $7.80 | $22.19 |
| Revenue Next Year | $4.77 | $24.33 |
| P/E Ratio | $31.30 | ★ $23.11 |
| Revenue Growth | 5.06 | ★ 27.63 |
| 52 Week Low | $78.87 | $13.50 |
| 52 Week High | $109.97 | $25.67 |
| Indicator | FELE | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 55.03 | 66.02 |
| Support Level | $92.20 | $19.13 |
| Resistance Level | $97.44 | $20.22 |
| Average True Range (ATR) | 2.16 | 0.73 |
| MACD | 0.30 | 0.05 |
| Stochastic Oscillator | 69.99 | 79.44 |
Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.